Global and China Oncology Biosimilars Market 2020 by Manufacturers, Type and Application, Forecast to 2025
Market Overview
The global Oncology Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 28.3% in the forecast period of 2020 to 2025 and will expected to reach USD 1323.1 million by 2025, from USD 487.9 million in 2019.
The Oncology Biosimilars market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Oncology Biosimilars market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Oncology Biosimilars market has been segmented into mAb, Immunomodulators, Hematopoietic Agents, G-CSF, Others, etc.
Breakdown by Application, Oncology Biosimilars has been segmented into Retail Pharmacies, Hospital Pharmacy, Online Pharmacy, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oncology Biosimilars market presented in the report. This section sheds light on the sales growth of different regional and country-level Oncology Biosimilars markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oncology Biosimilars market.
For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Oncology Biosimilars Market Share Analysis
Oncology Biosimilars competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Oncology Biosimilars sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oncology Biosimilars sales, revenue and market share for each player covered in this report.
The major players covered in Oncology Biosimilars are: Celltrion, Teva Pharmaceutical Industries Ltd, STADA Arzneimittel AG, Biocon, Sandoz International, Dr. Reddy's Laboratories, BIOCAD, Pfizer, Intas Pharmaceuticals, Apotex, etc. Among other players domestic and global, Oncology Biosimilars market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Oncology Biosimilars market are listed below:
Celltrion
Teva Pharmaceutical Industries Ltd
STADA Arzneimittel AG
Biocon
Sandoz International
Dr. Reddy's Laboratories
BIOCAD
Pfizer
Intas Pharmaceuticals
Apotex
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
mAb
Immunomodulators
Hematopoietic Agents
G-CSF
Others
Market segment by Application, can be divided into
Retail Pharmacies
Hospital Pharmacy
Online Pharmacy
Table of Contents
1 Market Overview
1.1 Oncology Biosimilars Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Oncology Biosimilars Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 mAb
1.2.3 Immunomodulators
1.2.4 Hematopoietic Agents
1.2.5 G-CSF
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Oncology Biosimilars Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacy
1.3.4 Online Pharmacy
1.4 Global Oncology Biosimilars Market Size and Forecast (2015-2025)
1.4.1 Global Oncology Biosimilars Revenue and Forecast (2015-2025)
1.4.2 Global Oncology Biosimilars Sales and Forecast (2015-2025)
1.5 Global Oncology Biosimilars Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 Celltrion
2.1.1 Celltrion Details
2.1.2 Celltrion Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Celltrion SWOT Analysis
2.1.4 Celltrion Product and Services
2.1.5 Celltrion Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Teva Pharmaceutical Industries Ltd
2.2.1 Teva Pharmaceutical Industries Ltd Details
2.2.2 Teva Pharmaceutical Industries Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Teva Pharmaceutical Industries Ltd SWOT Analysis
2.2.4 Teva Pharmaceutical Industries Ltd Product and Services
2.2.5 Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 STADA Arzneimittel AG
2.3.1 STADA Arzneimittel AG Details
2.3.2 STADA Arzneimittel AG Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 STADA Arzneimittel AG SWOT Analysis
2.3.4 STADA Arzneimittel AG Product and Services
2.3.5 STADA Arzneimittel AG Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Biocon
2.4.1 Biocon Details
2.4.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Biocon SWOT Analysis
2.4.4 Biocon Product and Services
2.4.5 Biocon Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sandoz International
2.5.1 Sandoz International Details
2.5.2 Sandoz International Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sandoz International SWOT Analysis
2.5.4 Sandoz International Product and Services
2.5.5 Sandoz International Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Dr. Reddy's Laboratories
2.6.1 Dr. Reddy's Laboratories Details
2.6.2 Dr. Reddy's Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Dr. Reddy's Laboratories SWOT Analysis
2.6.4 Dr. Reddy's Laboratories Product and Services
2.6.5 Dr. Reddy's Laboratories Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 BIOCAD
2.7.1 BIOCAD Details
2.7.2 BIOCAD Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 BIOCAD SWOT Analysis
2.7.4 BIOCAD Product and Services
2.7.5 BIOCAD Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Pfizer SWOT Analysis
2.8.4 Pfizer Product and Services
2.8.5 Pfizer Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Intas Pharmaceuticals
2.9.1 Intas Pharmaceuticals Details
2.9.2 Intas Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Intas Pharmaceuticals SWOT Analysis
2.9.4 Intas Pharmaceuticals Product and Services
2.9.5 Intas Pharmaceuticals Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Apotex
2.10.1 Apotex Details
2.10.2 Apotex Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Apotex SWOT Analysis
2.10.4 Apotex Product and Services
2.10.5 Apotex Oncology Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Oncology Biosimilars Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Oncology Biosimilars Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Oncology Biosimilars Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: China
3.2.1 Key Players Oncology Biosimilars Sales in China (2018-2019)
3.2.2 China Oncology Biosimilars Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Oncology Biosimilars Manufacturer Market Share in 2019
3.3.2 Top 6 Oncology Biosimilars Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Oncology Biosimilars Market Size by Geography (2015-2020)
4.1.1 Global Oncology Biosimilars Sales by Geography (2015-2020)
4.1.2 Global Oncology Biosimilars Revenue by Regions (2015-2020)
4.2 Global Oncology Biosimilars Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Oncology Biosimilars Sales and Forecast by Regions (2020-2025)
4.2.2 Global Oncology Biosimilars Revenue and Forecast by Regions (2020-2025)
4.3 North America Oncology Biosimilars Market Size and Forecast (2015-2025)
4.4 Europe Oncology Biosimilars Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Oncology Biosimilars Market Size and Forecast (2015-2025)
4.6 South America Oncology Biosimilars Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Oncology Biosimilars Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Oncology Biosimilars Market Size by Country (2015-2020)
5.1.1 North America Oncology Biosimilars Sales and Market Share by Country (2015-2020)
5.1.2 North America Oncology Biosimilars Revenue and Market Share by Country (2015-2020)
5.2 North America Oncology Biosimilars Market Size and Forecast by Country (2020-2025)
5.2.1 North America Oncology Biosimilars Sales and Forecast by Country (2020-2025)
5.2.2 North America Oncology Biosimilars Revenue and Forecast by Country (2020-2025)
5.3 United States Oncology Biosimilars Market Size and Forecast (2015-2025)
5.4 Canada Oncology Biosimilars Market Size and Forecast (2015-2025)
5.5 Mexico Oncology Biosimilars Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Oncology Biosimilars Market Size by Country (2015-2020)
6.1.1 Europe Oncology Biosimilars Sales by Country (2015-2020)
6.1.2 Europe Oncology Biosimilars Revenue by Country (2015-2020)
6.2 Europe Oncology Biosimilars Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Oncology Biosimilars Sales and Forecast by Country (2020-2025)
6.2.2 Europe Oncology Biosimilars Revenue and Forecast by Country (2020-2025)
6.3 Germany Oncology Biosimilars Market Size and Forecast (2015-2025)
6.4 United Kingdom Oncology Biosimilars Market Size and Forecast (2015-2025)
6.5 France Oncology Biosimilars Market Size and Forecast (2015-2025)
6.6 Russia Oncology Biosimilars Market Size and Forecast (2015-2025)
6.7 Italy Oncology Biosimilars Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Oncology Biosimilars Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Oncology Biosimilars Sales by Region (2015-2020)
7.1.2 Asia-Pacific Oncology Biosimilars Revenue by Region (2015-2020)
7.2 Asia-Pacific Oncology Biosimilars Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Oncology Biosimilars Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Oncology Biosimilars Revenue and Forecast by Region (2020-2025)
7.3 China Oncology Biosimilars Market Size and Forecast (2015-2025)
7.4 Japan Oncology Biosimilars Market Size and Forecast (2015-2025)
7.5 Korea Oncology Biosimilars Market Size and Forecast (2015-2025)
7.6 India Oncology Biosimilars Market Size and Forecast (2015-2025)
7.7 Southeast Asia Oncology Biosimilars Market Size and Forecast (2015-2025)
7.8 Australia Oncology Biosimilars Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Oncology Biosimilars Market Size by Country (2015-2020)
8.1.1 South America Oncology Biosimilars Sales by Country (2015-2020)
8.1.2 South America Oncology Biosimilars Revenue by Country (2015-2020)
8.2 South America Oncology Biosimilars Market Size and Forecast by Country (2020-2025)
8.2.1 South America Oncology Biosimilars Sales and Forecast by Country (2020-2025)
8.2.2 South America Oncology Biosimilars Revenue and Forecast by Country (2020-2025)
8.3 Brazil Oncology Biosimilars Market Size and Forecast (2015-2025)
8.4 Argentina Oncology Biosimilars Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Oncology Biosimilars Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Oncology Biosimilars Sales by Country (2015-2020)
9.1.2 Middle East & Africa Oncology Biosimilars Revenue by Country (2015-2020)
9.2 Middle East & Africa Oncology Biosimilars Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Oncology Biosimilars Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Oncology Biosimilars Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Oncology Biosimilars Market Size and Forecast (2015-2025)
9.4 Turkey Oncology Biosimilars Market Size and Forecast (2015-2025)
9.5 Egypt Oncology Biosimilars Market Size and Forecast (2015-2025)
9.6 South Africa Oncology Biosimilars Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Oncology Biosimilars Market Size by Type (2015-2020)
10.1.1 Global Oncology Biosimilars Sales by Type (2015-2020)
10.1.2 Global Oncology Biosimilars Revenue by Type (2015-2020)
10.1.3 Global Oncology Biosimilars Price by Type (2015-2020)
10.2 Global Oncology Biosimilars Market Size and Forecast by Type (2020-2025)
10.2.1 Global Oncology Biosimilars Sales and Forecast by Type (2020-2025)
10.2.2 Global Oncology Biosimilars Revenue and Forecast by Type (2020-2025)
10.2.3 Global Oncology Biosimilars Price and Forecast by Type (2020-2025)
10.3 China Oncology Biosimilars Market Size and Forecast by Type (2015-2025)
10.3.1 China Oncology Biosimilars Market Size by Type (2015-2020)
10.3.2 China Oncology Biosimilars Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Oncology Biosimilars Market Size by Application (2015-2020)
11.1.1 Global Oncology Biosimilars Sales by Application (2015-2020)
11.1.2 Global Oncology Biosimilars Revenue by Application (2015-2020)
11.1.3 Global Oncology Biosimilars Price by Application (2015-2020)
11.2 Global Oncology Biosimilars Market Size and Forecast by Application (2020-2025)
11.2.1 Global Oncology Biosimilars Sales and Forecast by Application (2020-2025)
11.2.2 Global Oncology Biosimilars Revenue and Forecast by Application (2020-2025)
11.2.3 Global Oncology Biosimilars Price and Forecast by Application (2020-2025)
11.3 China Oncology Biosimilars Market Size and Forecast by Application (2015-2025)
11.3.1 China Oncology Biosimilars Market Size by Application (2015-2020)
11.3.2 China Oncology Biosimilars Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Oncology Biosimilars Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oncology Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oncology Biosimilars Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Oncology Biosimilars Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Celltrion Basic Information, Manufacturing Base and Competitors
Table 6. Celltrion Oncology Biosimilars Major Business
Table 7. Celltrion Oncology Biosimilars Total Revenue (USD Million) (2018-2019)
Table 8. Celltrion SWOT Analysis
Table 9. Celltrion Oncology Biosimilars Product and Services
Table 10. Celltrion Oncology Biosimilars Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. Teva Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 12. Teva Pharmaceutical Industries Ltd Oncology Biosimilars Major Business
Table 13. Teva Pharmaceutical Industries Ltd Oncology Biosimilars Total Revenue (USD Million) (2018-2019)
Table 14. Teva Pharmaceutical Industries Ltd SWOT Analysis
Table 15. Teva Pharmaceutical Industries Ltd Oncology Biosimilars Product and Services
Table 16. Teva Pharmaceutical Industries Ltd Oncology Biosimilars Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. STADA Arzneimittel AG Basic Information, Manufacturing Base and Competitors
Table 18. STADA Arzneimittel AG Oncology Biosimilars Major Business
Table 19. STADA Arzneimittel AG Oncology Biosimilars Total Revenue (USD Million) (2018-2019)
Table 20. STADA Arzneimittel AG SWOT Analysis
Table 21. STADA Arzneimittel AG Oncology Biosimilars Product and Services
Table 22. STADA Arzneimittel AG Oncology Biosimilars Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 23. Biocon Basic Information, Manufacturing Base and Competitors
Table 24. Biocon Oncology Biosimilars Major Business
Table 25. Biocon Oncology Biosimilars Total Revenue (USD Million) (2018-2019)
Table 26. Biocon SWOT Analysis
Table 27. Biocon Oncology Biosimilars Product and Services
Table 28. Biocon Oncology Biosimilars Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 29. Sandoz International Basic Information, Manufacturing Base and Competitors
Table 30. Sandoz International Oncology Biosimilars Major Business
Table 31. Sandoz International Oncology Biosimilars Total Revenue (USD Million) (2018-2019)
Table 32. Sandoz International SWOT Analysis
Table 33. Sandoz International Oncology Biosimilars Product and Services
Table 34. Sandoz International Oncology Biosimilars Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 35. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 36. Dr. Reddy's Laboratories Oncology Biosimilars Major Business
Table 37. Dr. Reddy's Laboratories Oncology Biosimilars Total Revenue (USD Million) (2018-2019)
Table 38. Dr. Reddy's Laboratories SWOT Analysis
Table 39. Dr. Reddy's Laboratories Oncology Biosimilars Product and Services
Table 40. Dr. Reddy's Laboratories Oncology Biosimilars Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 41. BIOCAD Basic Information, Manufacturing Base and Competitors
Table 42. BIOCAD Oncology Biosimilars Major Business
Table 43. BIOCAD Oncology Biosimilars Total Revenue (USD Million) (2018-2019)
Table 44. BIOCAD SWOT Analysis
Table 45. BIOCAD Oncology Biosimilars Product and Services
Table 46. BIOCAD Oncology Biosimilars Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 47. Pfizer Basic Information, Manufacturing Base and Competitors
Table 48. Pfizer Oncology Biosimilars Major Business
Table 49. Pfizer Oncology Biosimilars Total Revenue (USD Million) (2018-2019)
Table 50. Pfizer SWOT Analysis
Table 51. Pfizer Oncology Biosimilars Product and Services
Table 52. Pfizer Oncology Biosimilars Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 53. Intas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Intas Pharmaceuticals Oncology Biosimilars Major Business
Table 55. Intas Pharmaceuticals Oncology Biosimilars Total Revenue (USD Million) (2018-2019)
Table 56. Intas Pharmaceuticals SWOT Analysis
Table 57. Intas Pharmaceuticals Oncology Biosimilars Product and Services
Table 58. Intas Pharmaceuticals Oncology Biosimilars Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 59. Apotex Basic Information, Manufacturing Base and Competitors
Table 60. Apotex Oncology Biosimilars Major Business
Table 61. Apotex Oncology Biosimilars Total Revenue (USD Million) (2018-2019)
Table 62. Apotex SWOT Analysis
Table 63. Apotex Oncology Biosimilars Product and Services
Table 64. Apotex Oncology Biosimilars Sales (K g), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 65. Global Oncology Biosimilars Sales by Manufacturer (2018-2019) (K g)
Table 66. Global Oncology Biosimilars Revenue by Manufacturer (2018-2019) (USD Million)
Table 67. Key Players Oncology Biosimilars Sales in China (2018-2019) (K g)
Table 68. Key Players Oncology Biosimilars Sales Market Share in China (2018-2019)
Table 69. Key Players Revenue of Oncology Biosimilars in China (2018-2019) (USD Million)
Table 70. Global Oncology Biosimilars Sales by Regions (2015-2020) (K g)
Table 71. Global Oncology Biosimilars Sales Market Share by Regions (2015-2020)
Table 72. Global Oncology Biosimilars Revenue by Regions (2015-2020) (USD Million)
Table 73. Global Oncology Biosimilars Sales and Forecast by Regions (2020-2025) (K g)
Table 74. Global Oncology Biosimilars Sales Market Share by Regions (2020-2025)
Table 75. Global Oncology Biosimilars Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 76. Global Oncology Biosimilars Revenue Market Share by Regions (2020-2025) (USD Million)
Table 77. North America Oncology Biosimilars Sales by Countries (2015-2020) (K g)
Table 78. North America Oncology Biosimilars Sales Market Share by Countries (2015-2020)
Table 79. North America Oncology Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 80. North America Oncology Biosimilars Revenue Market Share by Countries (2015-2020)
Table 81. North America Oncology Biosimilars Sales by Country (2020-2025) (K g)
Table 82. North America Oncology Biosimilars Sales Market Share by Country (2020-2025)
Table 83. North America Oncology Biosimilars Revenue by Country (2020-2025) (USD Million)
Table 84. North America Oncology Biosimilars Revenue Market Share by Country (2020-2025)
Table 85. Europe Oncology Biosimilars Sales by Countries (2015-2020) (K g)
Table 86. Europe Oncology Biosimilars Sales Market Share by Countries (2015-2020)
Table 87. Europe Oncology Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 88. Europe Oncology Biosimilars Revenue Market Share by Countries (2015-2020)
Table 89. Europe Oncology Biosimilars Sales by Country (2020-2025) (K g)
Table 90. Europe Oncology Biosimilars Sales Market Share by Country (2020-2025)
Table 91. Europe Oncology Biosimilars Revenue by Country (2020-2025) (USD Million)
Table 92. Europe Oncology Biosimilars Revenue Market Share by Country (2020-2025)
Table 93. Asia-Pacific Oncology Biosimilars Sales by Countries (2015-2020) (K g)
Table 94. Asia-Pacific Oncology Biosimilars Sales Market Share by Countries (2015-2020)
Table 95. Asia-Pacific Oncology Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 96. Asia-Pacific Oncology Biosimilars Revenue Market Share by Countries (2015-2020)
Table 97. Asia-Pacific Oncology Biosimilars Sales by Country (2020-2025) (K g)
Table 98. Asia-Pacific Oncology Biosimilars Sales Market Share by Country (2020-2025)
Table 99. Asia-Pacific Oncology Biosimilars Revenue by Country (2020-2025) (USD Million)
Table 100. Asia-Pacific Oncology Biosimilars Revenue Market Share by Country (2020-2025)
Table 101. South America Oncology Biosimilars Sales by Countries (2015-2020) (K g)
Table 102. South America Oncology Biosimilars Sales Market Share by Countries (2015-2020)
Table 103. South America Oncology Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 104. South America Oncology Biosimilars Revenue Market Share by Countries (2015-2020)
Table 105. South America Oncology Biosimilars Sales by Country (2020-2025) (K g)
Table 106. South America Oncology Biosimilars Sales Market Share by Country (2020-2025)
Table 107. South America Oncology Biosimilars Revenue by Country (2020-2025) (USD Million)
Table 108. South America Oncology Biosimilars Revenue Market Share by Country (2020-2025)
Table 109. Middle East & Africa Oncology Biosimilars Sales by Countries (2015-2020) (K g)
Table 110. Middle East & Africa Oncology Biosimilars Sales Market Share by Countries (2015-2020)
Table 111. Middle East & Africa Oncology Biosimilars Revenue by Countries (2015-2020) (USD Million)
Table 112. Middle East & Africa Oncology Biosimilars Revenue Market Share by Countries (2015-2020)
Table 113. Middle East & Africa Oncology Biosimilars Sales by Country (2020-2025) (K g)
Table 114. Middle East & Africa Oncology Biosimilars Sales Market Share by Country (2020-2025)
Table 115. Middle East & Africa Oncology Biosimilars Revenue by Country (2020-2025) (USD Million)
Table 116. Middle East & Africa Oncology Biosimilars Revenue Market Share by Country (2020-2025)
Table 117. China Oncology Biosimilars Sales by Type (2015-2020) (K g)
Table 118. China Oncology Biosimilars Sales Market Share by Type (2015-2020)
Table 119. China Oncology Biosimilars Revenue by Type (2015-2020) (USD Million)
Table 120. China Oncology Biosimilars Revenue Market Share by Type (2015-2020)
Table 121. China Oncology Biosimilars Sales by Type (2020-2025) (K g)
Table 122. China Oncology Biosimilars Sales Market Share by Type (2020-2025)
Table 123. China Oncology Biosimilars Revenue by Type (2020-2025) (USD Million)
Table 124. China Oncology Biosimilars Revenue Market Share by Type (2020-2025)
Table 125. Global Oncology Biosimilars Sales by Application (2015-2020) (K g)
Table 126. Global Oncology Biosimilars Sales Market Share by Application (2015-2020)
Table 127. Global Oncology Biosimilars Revenue by Application (2015-2020) (USD Million)
Table 128. Global Oncology Biosimilars Revenue Market Share by Application (2015-2020)
Table 129. Global Oncology Biosimilars Price by Application (2015-2020) (USD/Unit)
Table 130. Global Oncology Biosimilars Sales by Application (2020-2025) (K g)
Table 131. Global Oncology Biosimilars Sales Market Share by Application (2020-2025)
Table 132. Global Oncology Biosimilars Revenue by Application (2020-2025) (USD Million)
Table 133. Global Oncology Biosimilars Revenue Market Share by Application (2020-2025)
Table 134. Global Oncology Biosimilars Price by Application (2020-2025) (USD/Unit)
Table 135. China Oncology Biosimilars Sales by Application (2015-2020) (K g)
Table 136. China Oncology Biosimilars Sales Market Share by Application (2015-2020)
Table 137. China Oncology Biosimilars Revenue by Application (2015-2020) (USD Million)
Table 138. China Oncology Biosimilars Revenue Market Share by Application (2015-2020)
Table 139. China Oncology Biosimilars Sales by Application (2020-2025) (K g)
Table 140. China Oncology Biosimilars Sales Market Share by Application (2020-2025)
Table 141. China Oncology Biosimilars Revenue by Application (2020-2025) (USD Million)
Table 142. China Oncology Biosimilars Revenue Market Share by Application (2020-2025)
Table 143. Direct Channel Pros & Cons
Table 144. Indirect Channel Pros & Cons
Table 145. Distributors/Traders/ Dealers List
Table 146. Customers of Oncology Biosimilars
Table 147. Market Opportunities in Next Few Years
Table 148. Market Risks Analysis
Table 149. Market Drivers
List of Figures
Figure 1. Oncology Biosimilars Picture
Figure 2. Global Oncology Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. mAb Picture
Figure 4. Immunomodulators Picture
Figure 5. Hematopoietic Agents Picture
Figure 6. G-CSF Picture
Figure 7. Others Picture
Figure 8. Oncology Biosimilars Sales Market Share by Application in 2019
Figure 9. Retail Pharmacies Picture
Figure 10. Hospital Pharmacy Picture
Figure 11. Online Pharmacy Picture
Figure 12. Global Oncology Biosimilars Market Status and Outlook (2015-2025) (USD Million)
Figure 13. Global Oncology Biosimilars Sales Growth Rate (2015-2025) (K g)
Figure 14. Global Oncology Biosimilars Sales Market Share by Manufacturer in 2019
Figure 15. Global Oncology Biosimilars Revenue Market Share by Manufacturer in 2019
Figure 16. Key Players Oncology Biosimilars Revenue Market Share in China in 2019
Figure 17. Global Top 5 Oncology Biosimilars Manufacturer Market Share in 2019
Figure 18. Top 3 Oncology Biosimilars Players Market Share in China in 2019
Figure 19. Global Oncology Biosimilars Revenue Market Share by Regions in 2019
Figure 20. North America Oncology Biosimilars Sales YoY Growth (2015-2025) (K g)
Figure 21. North America Oncology Biosimilars Revenue YoY Growth (2015-2025) (USD Million)
Figure 22. Europe Oncology Biosimilars Sales YoY Growth (2015-2020) (K g)
Figure 23. Europe Oncology Biosimilars Revenue YoY Growth (2015-2020) (USD Million)
Figure 24. Asia-Pacific Oncology Biosimilars Sales YoY Growth (2015-2020) (K g)
Figure 25. Asia-Pacific Oncology Biosimilars Revenue YoY Growth (2015-2020) (USD Million)
Figure 26. South America Oncology Biosimilars Sales YoY Growth (2015-2020) (K g)
Figure 27. South America Oncology Biosimilars Revenue YoY Growth (2015-2020) (USD Million)
Figure 28. Middle East & Africa Oncology Biosimilars Sales YoY Growth (2015-2020) (K g)
Figure 29. Middle East & Africa Oncology Biosimilars Revenue YoY Growth (2015-2020) (USD Million)
Figure 30. North America Oncology Biosimilars Sales Market Share by Country in 2019
Figure 31. North America Oncology Biosimilars Revenue Market Share by Country in 2019
Figure 32. United States Oncology Biosimilars Market Size and Growth Rate (2015-2025) (USD Million)
Figure 33. Canada Oncology Biosimilars Market Size and Growth Rate (2015-2025) (USD Million)
Figure 34. Mexico Oncology Biosimilars Market Size and Growth Rate (2015-2020) (USD Million)
Figure 35. Europe Oncology Biosimilars Revenue Market Share by Country in 2019
Figure 36. Germany Oncology Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. United Kingdom Oncology Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 38. France Oncology Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 39. Russia Oncology Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 40. Italy Oncology Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. Asia-Pacific Oncology Biosimilars Sales Market Share by Region 2018
Figure 42. Asia-Pacific Oncology Biosimilars Revenue Market Share by Region 2018
Figure 43. China Oncology Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Japan Oncology Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. Korea Oncology Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 46. India Oncology Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 47. Southeast Asia Oncology Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 48. Australia Oncology Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. South America Oncology Biosimilars Sales Market Share by Country in 2019
Figure 50. South America Oncology Biosimilars Revenue Market Share by Country in 2019
Figure 51. Brazil Oncology Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. Argentina Oncology Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. Saudi Arabia Oncology Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 54. Turkey Oncology Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 55. Egypt Oncology Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 56. South Africa Oncology Biosimilars Market Size Growth Rate (2015-2025) (USD Million)
Figure 57. Global Revenue Market Share of Oncology Biosimilars by Type in 2019
Figure 58. Global Revenue Market Share of Oncology Biosimilars by Application in 2019
Figure 59. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
Celltrion
Teva Pharmaceutical Industries Ltd
STADA Arzneimittel AG
Biocon
Sandoz International
Dr. Reddy's Laboratories
BIOCAD
Pfizer
Intas Pharmaceuticals
Apotex
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets